United Capital Financial Advisors LLC Purchases Shares of 3,499 Axon Enterprise, Inc $AXON

United Capital Financial Advisors LLC acquired a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 3,499 shares of the biotechnology company’s stock, valued at approximately $1,962,000.

A number of other institutional investors also recently modified their holdings of AXON. Creative Financial Designs Inc. ADV bought a new stake in Axon Enterprise during the 4th quarter worth approximately $28,000. Keating Financial Advisory Services Inc. acquired a new stake in Axon Enterprise during the 2nd quarter valued at $31,000. AlphaCentric Advisors LLC bought a new position in Axon Enterprise in the 4th quarter valued at $34,000. Darwin Wealth Management LLC bought a new position in Axon Enterprise in the 2nd quarter valued at $37,000. Finally, Strive Financial Group LLC acquired a new position in Axon Enterprise in the fourth quarter worth $41,000. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 20,000 shares of Axon Enterprise stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $10,000,000.00. Following the completion of the sale, the chief executive officer owned 3,060,997 shares of the company’s stock, valued at approximately $1,530,498,500. The trade was a 0.65% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the company’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total transaction of $753,690.00. Following the sale, the insider owned 34,024 shares of the company’s stock, valued at $16,501,640. The trade was a 4.37% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 76,594 shares of company stock valued at $41,236,386. 4.20% of the stock is currently owned by company insiders.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON opened at $600.73 on Friday. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $792.16. The stock has a market capitalization of $48.80 billion, a P/E ratio of 249.27, a P/E/G ratio of 9.92 and a beta of 1.39. The business has a 50-day moving average price of $560.75 and a two-hundred day moving average price of $482.99.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The company had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. During the same quarter last year, the firm earned $2.12 EPS. The company’s revenue for the quarter was up 35.3% on a year-over-year basis. Equities analysts predict that Axon Enterprise, Inc will post 2.04 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on AXON shares. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $715.00 price target on shares of Axon Enterprise in a report on Thursday, August 6th. Citizens Jmp reiterated a “market outperform” rating and set a $700.00 price target on shares of Axon Enterprise in a research report on Thursday, June 25th. Royal Bank Of Canada reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, July 21st. Finally, Needham & Company LLC restated a “buy” rating on shares of Axon Enterprise in a research report on Thursday, August 6th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $730.92.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.